UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number No. 001-42155
Ping An Biomedical Co., Ltd.
(Registrant’s Name)
22/F, China United Plaza
1002-1008, Tai Nan West Street
Cheung Sha Wan
Kowloon, Hong Kong
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
On July 22, 2026, Ping An Biomedical Co., Ltd. (the “Company”) issued a press release announcing the Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years.
A copy of the press release is furnished as Exhibit 99.1 to this Form 6-K.
Exhibits
| Exhibit No. | Description of Exhibit | |
| 99.1 | Press Release, dated July 22, 2026 |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PING AN BIOMEDICAL CO., LTD. | ||
| Date: July 22, 2026 | By: | /s/ Pijun Liu |
| Name: | Pijun Liu | |
| Title: | Chairman of the Board of Directors | |
2